FDA proposes randomized, controlled testing for incontinence devices

10/5/2008 | FDAnews

The easiest way to obtain data on the safety and effectiveness of urinary incontinence devices is to conduct randomized, controlled clinical studies, according to an FDA draft guidance. Such trials can help overcome major issues in testing the products, including the diversity of the general patient population. The agency will accept comments on the draft until Dec. 18.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA